Login to Your Account

NewCo News: MingSight to Offer 'Bright' Solution for Diabetic Eye Disease

By Marie Powers

Wednesday, June 15, 2011
Using technology acquired from Pfizer Inc., San Diego-based biotech MingSight Pharmaceuticals Inc. has its eye on an oral therapy for retinal diseases.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription